Fragment-based Discovery of a Small-Molecule Protein Kinase C-iota Inhibitor Binding Post-kinase Domain Residues.
Kwiatkowski, J., Baburajendran, N., Poulsen, A., Liu, B., Tee, D.H.Y., Wong, Y.X., Poh, Z.Y., Ong, E.H., Dinie, N., Cherian, J., Jansson, A.E., Hill, J., Keller, T.H., Hung, A.W.(2019) ACS Med Chem Lett 10: 318-323
- PubMed: 30891133 
- DOI: 10.1021/acsmedchemlett.8b00546
- Primary Citation of Related Structures:  
6ILZ - PubMed Abstract: 
The atypical protein kinase C-iota (PKC-ι) enzyme is implicated in various cancers and has been put forward as an attractive target for developing anticancer therapy. A high concentration biochemical screen identified pyridine fragment weakly inhibiting PKC-ι with IC 50 = 424 μM ...